{
    "Trade/Device Name(s)": [
        "Acucy Influenza A&B Test with the Acucy 2 System",
        "Acucy 2 Reader with Influenza A/B"
    ],
    "Submitter Information": "Sekisui Diagnostics, LLC",
    "510(k) Number": "K241188",
    "Predicate Device Reference 510(k) Number(s)": [
        "K182001"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "PSZ"
    ],
    "Summary Letter Date": "April 27, 2024",
    "Summary Letter Received Date": "April 29, 2024",
    "Submission Date": "April 17, 2025",
    "Regulation Number(s)": [
        "21 CFR 866.3328"
    ],
    "Regulation Name(s)": [
        "Influenza Virus Antigen Detection Test System"
    ],
    "Analyte Class(es)": [
        "microbiology",
        "virology",
        "POCT"
    ],
    "Analyte(s)": [
        "Influenza A viral nucleoprotein antigen",
        "Influenza B viral nucleoprotein antigen"
    ],
    "Specimen Type(s)": [
        "Anterior nasal swab",
        "Nasopharyngeal swab"
    ],
    "Specimen Container(s)": [
        "Extraction Buffer vial"
    ],
    "Instrument(s)/Platform(s)": [
        "Acucy 2 Reader",
        "Acucy Reader"
    ],
    "Method(s)/Technology(ies)": [
        "Rapid chromatographic immunoassay",
        "Lateral flow",
        "Cassette-based detection",
        "Colloidal gold conjugate immunoassay"
    ],
    "Methodologies": [
        "Qualitative antigen detection",
        "Absorbance intensity measurement"
    ],
    "Submission Type(s)": [
        "Assay",
        "Instrument",
        "Test",
        "Cassette",
        "Reader",
        "Extraction buffer",
        "Swab",
        "Workstation",
        "Quality control material"
    ],
    "Document Summary": "FDA 510(k) summary for Acucy Influenza A&B Test with Acucy 2 System, a rapid chromatographic immunoassay for qualitative detection and differentiation of influenza A and B antigens using nasal and nasopharyngeal swabs.",
    "Indications for Use Summary": "A rapid chromatographic immunoassay for qualitative detection and differentiation of influenza A and B viral nucleoprotein antigens directly from anterior nasal and nasopharyngeal swabs of patients with signs and symptoms of respiratory infection, used with Acucy or Acucy 2 Reader as an aid in diagnosis; not intended for influenza C detection; negative results are presumptive and should be confirmed.",
    "fda_folder": "Microbiology"
}